AbCellera Biologics Inc. ABCL FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s FX effect on cash?
- AbCellera Biologics Inc. (ABCL) reported FX effect on cash of -$38K in Q1 2026.
- How has AbCellera Biologics Inc.'s FX effect on cash changed year-over-year?
- AbCellera Biologics Inc.'s FX effect on cash decreased by 106.4% year-over-year, from $590K to -$38K.
- What is the long-term trend for AbCellera Biologics Inc.'s FX effect on cash?
- Over 2 years (2021 to 2023), AbCellera Biologics Inc.'s FX effect on cash has grown at a -35.7% compound annual growth rate (CAGR), from -$1.43M to $589K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.